About us
Company activity
Core values
By embodying these values—commitment, agility, responsibility, and expertise—Biose demonstrates its dedication to advancing healthcare and improving patient outcomes. As we continue to grow and evolve, these values will remain at the core of everything we do, guiding our actions and shaping our future success.
Management team
Adrien NIVOLIEZ
CEO
Claire DERLOT
VP Business & Programs
Samuel BRISSEZ
VP Process
Fabrice GONIN
VP Quality & QP
Caroline DAUSSET
VP Analytics
Bertrand CLAUX
VP Human Resources
Paul-Marie CHASSAING
VP Finance
Nadine DAOU
VP US Operations
Anneclaude ADAM-SCHNIDER
KEY ACCOUNT MANAGER
Richard ELLIS
Business development director
Company History
2023
Adrien NIVOLIEZ becomes the Chairman and CEO of BIOSE Industrie and the company continues as the world leading CDMO
350 employees
February 2023
BIOSE Industrie raises a joint investment of €80M by L-GAM and the French State through the French Tech Souveraineté scheme and creates 200 jobs
150 employees
Septembre 2020
Creation of new offices in Boston, USA
2021
BIOSE Industrie is granted €5M by the French State as part of the France Relance scheme
July 2020
With the support of Cathay Capital, BIOSE Industrie invests €40M in its Aurillac plant
January 2020
BIOSE and BIOSE Industrie merge to become BIOSE Industrie
60 employees
2015
2017
Adrien NIVOLIEZ becomes the CEO of BIOSE Industrie
2011
Creation of PROBIONIOV, a subsidiary of LYOCENTRE, with a new commercial department in Clermont-Ferrand and the R&D department in Aurillac
2008
Creation of a Research and Development (R&D) department
1997
Acquisition of LYOCENTRE by Hubert DESJONQUERES, implementing a policy of commercial and industrial revitalization
2005-2007
Consolidation of the manufacturing facilities at the Aurillac plant
2007
Stanislas DESJONQUERES becomes the CEO of LYOCENTRE
1975
Creation of the Aurillac plant
1958-1978
Development of the Saint-Simon plant
1951
Creation of LYOCENTRE